These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18321323)

  • 1. Re: Outcome after cytoreductive nephrectomy for metastatic renal cell carcinoma is predicted by fractional percentage of tumour volume removed.
    Kirollos M
    BJU Int; 2008 Apr; 101(7):906; author reply 906-7. PubMed ID: 18321323
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcome after cytoreductive nephrectomy for metastatic renal cell carcinoma is predicted by fractional percentage of tumour volume removed.
    Pierorazio PM; McKiernan JM; McCann TR; Mohile S; Petrylak D; Benson MC
    BJU Int; 2007 Oct; 100(4):755-9. PubMed ID: 17822456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Healy KA; Marshall FF; Ogan K
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1295-304. PubMed ID: 16925495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoreductive nephrectomy for metastatic renal cell carcinoma: is it still imperative in the era of targeted therapy?
    Pantuck AJ; Belldegrun AS; Figlin RA
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):693s-696s. PubMed ID: 17255295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Capitanio et al.: Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study. (Urology 2008;72:1090-1095).
    Chung SD; Chu SH; Tsai CC
    Urology; 2009 Mar; 73(3):682-3; author reply 683-4. PubMed ID: 19248907
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy.
    Tatokoro M; Saito K; Iimura Y; Fujii Y; Kawakami S; Kihara K
    J Urol; 2008 Aug; 180(2):515-9. PubMed ID: 18550105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy.
    Kwan KG; Kapoor A
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Against: The case for cytoreductive nephrectomy for the management of metastatic renal cell carcinoma.
    Carver BS
    J Urol; 2009 Sep; 182(3):833-4. PubMed ID: 19616224
    [No Abstract]   [Full Text] [Related]  

  • 9. The once and future role of cytoreductive nephrectomy.
    Neill MG; Jewett MA
    Urol Oncol; 2008; 26(4):346-52. PubMed ID: 18367110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Margulis V; Matin SF; Wood CG
    Curr Opin Urol; 2008 Sep; 18(5):474-80. PubMed ID: 18670270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cytoreductive nephrectomy for renal cell carcinoma in the era of targeted therapy.
    Chowdhury S; Harper PG; Choueiri TK
    Nat Clin Pract Oncol; 2008 Dec; 5(12):698-9. PubMed ID: 18852722
    [No Abstract]   [Full Text] [Related]  

  • 12. Why not partial nephrectomy?
    Navai N; Ramos P; Zhao LC; Meeks JJ; Nadler RB; Smith ND
    Urology; 2008 Aug; 72(2):243-6. PubMed ID: 18584853
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytoreductive nephrectomy for metastatic renal cell carcinoma.
    McKiernan J; Wood CG
    J Urol; 2013 Aug; 190(2):386-8. PubMed ID: 23702308
    [No Abstract]   [Full Text] [Related]  

  • 14. Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma.
    Zini L; Capitanio U; Perrotte P; Jeldres C; Shariat SF; Arjane P; Widmer H; Montorsi F; Patard JJ; Karakiewicz PI
    Urology; 2009 Feb; 73(2):342-6. PubMed ID: 19041122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical intervention in patients with metastatic renal cancer: metastasectomy and cytoreductive nephrectomy.
    Russo P; O'Brien MF
    Urol Clin North Am; 2008 Nov; 35(4):679-86; viii. PubMed ID: 18992621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study.
    Capitanio U; Zini L; Perrotte P; Shariat SF; Jeldres C; Arjane P; Pharand D; Widmer H; Péloquin F; Montorsi F; Patard JJ; Karakiewicz PI
    Urology; 2008 Nov; 72(5):1090-5. PubMed ID: 18799207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. For: Radical nephrectomy in the setting of metastatic renal cell cancer: proceed judiciously.
    Aron M; Gill IS
    J Urol; 2009 Sep; 182(3):832-3. PubMed ID: 19643447
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Puppo P, Introini C, Calvi P, Naselli A. Long term results of excision of small renal cancer surrounded by a minimal layer of grossly normal parenchyma: review of 94 cases. Eur Urol 2004;46:477-81.
    Carini M; Lapini A; Minervini A; Serni S
    Eur Urol; 2005 Feb; 47(2):265-6; author reply 266. PubMed ID: 15661426
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment.
    Wood DP
    J Urol; 2009 Nov; 182(5):2176. PubMed ID: 19758630
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial comment.
    Pouliot F; Belldegrun A
    Urology; 2009 Sep; 74(3):641-2; author reply 642. PubMed ID: 19716921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.